Genetics of liver disease: From pathophysiology to clinical practice

Journal of Hepatology

Volumn 62, Issue S1, 2015, Pages S6-S14

  Karlsen, Tom H ^a,b   Lammert, Frank ^c,d   Thompson, Richard J ^e  

^a OSLO UNIVERSITY HOSPITAL   (Norway)

^b UNIVERSITY OF OSLO   (Norway)

^c SAARLAND UNIVERSITY   (Germany)

^d SAARLAND UNIVERSITY   (Germany)

^e KING'S COLLEGE LONDON   (United Kingdom)

Author keywords

Human genetics; Mendelian disease; Multifactorial disease

Indexed keywords

ABC TRANSPORTER G5; FERROPORTIN; SITOSTEROL; TRANSFERRIN RECEPTOR 2; ADIPONUTRIN, HUMAN; MEMBRANE PROTEIN; TRIACYLGLYCEROL LIPASE;

ADAPTIVE IMMUNITY; ALAGILLE SYNDROME; AUTOIMMUNE HEPATITIS; CLINICAL PRACTICE; CRIGLER NAJJAR SYNDROME; DUBIN JOHNSON SYNDROME; ENVIRONMENTAL FACTOR; GALLSTONE; GENE IDENTIFICATION; GENE MUTATION; GENETIC ASSOCIATION; GENETIC SUSCEPTIBILITY; GENETICS; HAPLOTYPE; HEMOCHROMATOSIS; HUMAN; IRON METABOLISM; LIVER CELL CARCINOMA; LIVER DISEASE; PATHOPHYSIOLOGY; PATIENT CARE; PERSONALIZED MEDICINE; PRIMARY BILIARY CIRRHOSIS; PRIMARY SCLEROSING CHOLANGITIS; PRIORITY JOURNAL; REVIEW; SINGLE NUCLEOTIDE POLYMORPHISM; WILSON DISEASE; CLASSIFICATION; EXOME; GENETIC PREDISPOSITION;

EXOME; GENETIC PREDISPOSITION TO DISEASE; GENETICS; GENOME-WIDE ASSOCIATION STUDY; HUMANS; LIPASE; LIVER DISEASES; MEMBRANE PROTEINS; POLYMORPHISM, SINGLE NUCLEOTIDE;

EID: 84947051255     PISSN: 01688278     EISSN: 16000641     Source Type: Journal    
DOI: 10.1016/j.jhep.2015.02.025     Document Type: Review

References (109)

1. I.R. Mackay, and P.J. Morris Association of autoimmune active chronic hepatitis with HL-A1,8 Lancet 2 1972 793 795
2. G. Ercilla, A. Pares, F. Arriaga, M. Bruguera, R. Castillo, J. Rodes, and et al. Primary biliary cirrhosis associated with HLA-DRw3 Tissue Antigens 14 1979 449 452
3. E. Schrumpf, O. Fausa, O. Forre, J.H. Dobloug, S. Ritland, and E. Thorsby HLA antigens and immunoregulatory T cells in ulcerative colitis associated with hepatobiliary disease Scand J Gastroenterol 17 1982 187 191
4. B. Kerem, J.M. Rommens, J.A. Buchanan, D. Markiewicz, T.K. Cox, A. Chakravarti, and et al. Identification of the cystic fibrosis gene: genetic analysis Science 245 1989 1073 1080
5. O. Koiwai, M. Nishizawa, K. Hasada, S. Aono, Y. Adachi, N. Mamiya, and et al. Gilbert's syndrome is caused by a heterozygous missense mutation in the gene for bilirubin UDP-glucuronosyltransferase Hum Mol Genet 4 1995 1183 1186
6. P.J. Bosma, J.R. Chowdhury, T.J. Huang, P. Lahiri, R.P. Elferink, H.H. Van Es, and et al. Mechanisms of inherited deficiencies of multiple UDP-glucuronosyltransferase isoforms in two patients with Crigler-Najjar syndrome, type I FASEB J 6 1992 2859 2863
7. N. Moghrabi, D.J. Clarke, M. Boxer, and B. Burchell Identification of an A-to-G missense mutation in exon 2 of the UGT1 gene complex that causes Crigler-Najjar syndrome type 2 Genomics 18 1993 171 173
8. K. Petrukhin, S.G. Fischer, M. Pirastu, R.E. Tanzi, I. Chernov, M. Devoto, and et al. Mapping, cloning and genetic characterization of the region containing the Wilson disease gene Nat Genet 5 1993 338 343
9. P.C. Bull, G.R. Thomas, J.M. Rommens, J.R. Forbes, and D.W. Cox The Wilson disease gene is a putative copper transporting P-type ATPase similar to the Menkes gene Nat Genet 5 1993 327 337
10. J.N. Feder, A. Gnirke, W. Thomas, Z. Tsuchihashi, D.A. Ruddy, A. Basava, and et al. A novel MHC class I-like gene is mutated in patients with hereditary haemochromatosis Nat Genet 13 1996 399 408
11. C.C. Paulusma, M. Kool, P.J. Bosma, G.L. Scheffer, F. Ter Borg, R.J. Scheper, and et al. A mutation in the human canalicular multispecific organic anion transporter gene causes the Dubin-Johnson syndrome Hepatology 25 1997 1539 1542
12. R. McDaniell, D.M. Warthen, P.A. Sanchez-Lara, A. Pai, I.D. Krantz, D.A. Piccoli, and et al. NOTCH2 mutations cause Alagille syndrome, a heterogeneous disorder of the notch signaling pathway Am J Hum Genet 79 2006 169 173
13. B.M. Kamath, R.C. Bauer, K.M. Loomes, G. Chao, J. Gerfen, A. Hutchinson, and et al. NOTCH2 mutations in Alagille syndrome J Med Genet 49 2012 138 144
14. L.N. Bull, M.J. van Eijk, L. Pawlikowska, J.A. DeYoung, J.A. Juijn, M. Liao, and et al. A gene encoding a P-type ATPase mutated in two forms of hereditary cholestasis Nat Genet 18 1998 219 224
15. S.S. Strautnieks, L.N. Bull, A.S. Knisely, S.A. Kocoshis, N. Dahl, H. Arnell, and et al. A gene encoding a liver-specific ABC transporter is mutated in progressive familial intrahepatic cholestasis Nat Genet 20 1998 233 238
16. J.M. De Vree, E. Jacquemin, E. Sturm, D. Cresteil, P.J. Bosma, J. Aten, and et al. Mutations in the MDR3 gene cause progressive familial intrahepatic cholestasis Proc Natl Acad Sci U S A 95 1998 282 287
17. G. Montosi, A. Donovan, A. Totaro, C. Garuti, E. Pignatti, S. Cassanelli, and et al. Autosomal-dominant hemochromatosis is associated with a mutation in the ferroportin (SLC11A3) gene J Clin Invest 108 2001 619 623
18. O.T. Njajou, N. Vaessen, M. Joosse, B. Berghuis, J.W. van Dongen, M.H. Breuning, and et al. A mutation in SLC11A3 is associated with autosomal dominant hemochromatosis Nat Genet 28 2001 213 214
19. D. Girelli, C. Bozzini, A. Roetto, F. Alberti, F. Daraio, R. Colombari, and et al. Clinical and pathologic findings in hemochromatosis type 3 due to a novel mutation in transferrin receptor 2 gene Gastroenterology 122 2002 1295 1302
20. A. Roetto, G. Papanikolaou, M. Politou, F. Alberti, D. Girelli, J. Christakis, and et al. Mutant antimicrobial peptide hepcidin is associated with severe juvenile hemochromatosis Nat Genet 33 2003 21 22
21. G. Papanikolaou, M.E. Samuels, E.H. Ludwig, M.L. MacDonald, P.L. Franchini, M.P. Dube, and et al. Mutations in HFE2 cause iron overload in chromosome 1q-linked juvenile hemochromatosis Nat Genet 36 2004 77 82
22. S. Buch, C. Schafmayer, H. Völzke, C. Becker, A. Franke, H. von Eller-Eberstein, and et al. A genome-wide association scan identifies the hepatic cholesterol transporter ABCG8 as a susceptibility factor for human gallstone disease Nat Genet 39 2007 995 999
23. S. Romeo, J. Kozlitina, C. Xing, A. Pertsemlidis, D. Cox, L.A. Pennacchio, and et al. Genetic variation in PNPLA3 confers susceptibility to nonalcoholic fatty liver disease Nat Genet 40 2008 1461 1465
24. X. Yuan, D. Waterworth, J.R. Perry, N. Lim, K. Song, J.C. Chambers, and et al. Population-based genome-wide association studies reveal six loci influencing plasma levels of liver enzymes Am J Hum Genet 83 2008 520 528
25. G.M. Hirschfield, X. Liu, C. Xu, Y. Lu, G. Xie, Y. Lu, and et al. Primary biliary cirrhosis associated with HLA, IL12A, and IL12RB2 variants N Engl J Med 360 2009 2544 2555
26. A.K. Daly, P.T. Donaldson, P. Bhatnagar, Y. Shen, I. Pe'er, A. Floratos, and et al. HLA-B∗5701 genotype is a major determinant of drug-induced liver injury due to flucloxacillin Nat Genet 41 2009 816 819
27. Y. Kamatani, S. Wattanapokayakit, H. Ochi, T. Kawaguchi, A. Takahashi, N. Hosono, and et al. A genome-wide association study identifies variants in the HLA-DP locus associated with chronic hepatitis B in Asians Nat Genet 41 2009 591 595
28. D. Ge, J. Fellay, A.J. Thompson, J.S. Simon, K.V. Shianna, T.J. Urban, and et al. Genetic variation in IL28B predicts hepatitis C treatment-induced viral clearance Nature 461 2009 399 401
29. D.L. Thomas, C.L. Thio, M.P. Martin, Y. Qi, D. Ge, C. O'Huigin, and et al. Genetic variation in IL28B and spontaneous clearance of hepatitis C virus Nature 461 2009 798 801
30. J.R. Bartlett, K.J. Friedman, S.C. Ling, R.G. Pace, S.C. Bell, B. Bourke, and et al. Genetic modifiers of liver disease in cystic fibrosis JAMA 302 2009 1076 1083
31. C. Tian, R.P. Stokowski, D. Kershenobich, D.G. Ballinger, and D.A. Hinds Variant in PNPLA3 is associated with alcoholic liver disease Nat Genet 42 2010 21 23
32. T.H. Karlsen, A. Franke, E. Melum, A. Kaser, J.R. Hov, T. Balschun, and et al. Genome-wide association analysis in primary sclerosing cholangitis Gastroenterology 138 2010 1102 1111
33. J. Fellay, A.J. Thompson, D. Ge, C.E. Gumbs, T.J. Urban, K.V. Shianna, and et al. ITPA gene variants protect against anaemia in patients treated for chronic hepatitis C Nature 464 2010 405 408
34. H. Zhang, Y. Zhai, Z. Hu, C. Wu, J. Qian, W. Jia, and et al. Genome-wide association study identifies 1p36.22 as a new susceptibility locus for hepatocellular carcinoma in chronic hepatitis B virus carriers Nat Genet 42 2010 755 758
35. M.I. Lucena, M. Molokhia, Y. Shen, T.J. Urban, G.P. Aithal, R.J. Andrade, and et al. Susceptibility to amoxicillin-clavulanate-induced liver injury is influenced by multiple HLA class I and II alleles Gastroenterology 141 2011 338 347
36. E. Van de Steeg, V. Stranecky, H. Hartmannova, L. Noskova, M. Hrebicek, E. Wagenaar, and et al. Complete OATP1B1 and OATP1B3 deficiency causes human Rotor syndrome by interrupting conjugated bilirubin reuptake into the liver J Clin Invest 122 2012 519 528
37. E. Patin, Z. Kutalik, J. Guergnon, S. Bibert, B. Nalpas, E. Jouanguy, and et al. Genome-wide association study identifies variants associated with progression of liver fibrosis from HCV infection Gastroenterology 143 2012 1244 1252
38. Y.S. De Boer, N.M. van Gerven, A. Zwiers, B.J. Verwer, B. van Hoek, K.J. van Erpecum, and et al. Genome-wide association study identifies variants associated with autoimmune hepatitis type 1 Gastroenterology 147 2014 e445
39. M. Sambrotta, S. Strautnieks, E. Papouli, P. Rushton, B.E. Clark, D.A. Parry, and et al. Mutations in TJP2 cause progressive cholestatic liver disease Nat Genet 46 2014 326 328
40. L. Pan, L. Zhang, W. Zhang, X. Wu, Y. Li, B. Yan, and et al. A genome-wide association study identifies polymorphisms in the HLA-DR region associated with non-response to hepatitis B vaccination in Chinese Han populations Hum Mol Genet 23 2014 2210 2219
41. F. Lammert Hereditary liver diseases. Preface Best Pract Res Clin Gastroenterol 24 2010 529
42. R. Pinyol, J.C. Nault, I.M. Quetglas, J. Zucman-Rossi, and J.M. Llovet Molecular profiling of liver tumors: classification and clinical translation for decision making Semin Liver Dis 34 2014 363 375
43. R. Rosencrantz, and M. Schilsky Wilson disease: pathogenesis and clinical considerations in diagnosis and treatment Semin Liver Dis 31 2011 245 259
44. M.W. Hentze, M.U. Muckenthaler, and N.C. Andrews Balancing acts: molecular control of mammalian iron metabolism Cell 117 2004 285 297
45. P. Aguilar-Martinez, B. Grandchamp, S. Cunat, E. Cadet, F. Blanc, M. Nourrit, and et al. Iron overload in HFE C282Y heterozygotes at first genetic testing: a strategy for identifying rare HFE variants Haematologica 96 2011 507 514
46. G.M. Hirschfield, R.W. Chapman, T.H. Karlsen, F. Lammert, K.N. Lazaridis, and A.L. Mason The genetics of complex cholestatic disorders Gastroenterology 144 2013 1357 1374
47. K.E. Berge, H. Tian, G.A. Graf, L. Yu, N.V. Grishin, J. Schultz, and et al. Accumulation of dietary cholesterol in sitosterolemia caused by mutations in adjacent ABC transporters Science 290 2000 1771 1775
48. A. Buil, A.A. Brown, T. Lappalainen, A. Vinuela, M.N. Davies, H.F. Zheng, and et al. Gene-gene and gene-environment interactions detected by transcriptome sequence analysis in twins Nat Genet 47 2015 88 91
49. E.K. Henriksen, E. Melum, and T.H. Karlsen Update on primary sclerosing cholangitis genetics Curr Opin Gastroenterol 30 2014 310 319
50. T. Folseraas, E. Melum, P. Rausch, B.D. Juran, E. Ellinghaus, A. Shiryaev, and et al. Extended analysis of a genome-wide association study in primary sclerosing cholangitis detects multiple novel risk loci J Hepatol 57 2012 366 375
51. J.Z. Liu, M.A. Almarri, D.J. Gaffney, G.F. Mells, L. Jostins, H.J. Cordell, and et al. Dense fine-mapping study identifies new susceptibility loci for primary biliary cirrhosis Nat Genet 44 2012 1137 1141
52. J.Z. Liu, J.R. Hov, T. Folseraas, E. Ellinghaus, S.M. Rushbrook, N.T. Doncheva, and et al. Dense genotyping of immune-related disease regions identifies nine new risk loci for primary sclerosing cholangitis Nat Genet 45 2013 670 675
53. G.M. Hirschfield, and T.H. Karlsen Genetic risks link autoimmune hepatitis to other autoimmune liver disease Gastroenterology 147 2014 270 273
54. C.F. Wright, P. Brice, A. Stewart, and H. Burton Realising the benefits of genetics for health Lancet 376 2010 1370 1371
55. S. Vilarinho, M. Choi, D. Jain, A. Malhotra, S. Kulkarni, D. Pashankar, and et al. Individual exome analysis in diagnosis and management of paediatric liver failure of indeterminate aetiology J Hepatol 61 2014 1056 1063
56. R.J. Clayton, F.L. Iber, B.H. Ruebner, and V.A. McKusick Byler disease. Fatal familial intrahepatic cholestasis in an Amish kindred Am J Dis Child 117 1969 112 124
57. B. Hagenbuch, and P.J. Meier Molecular cloning, chromosomal localization, and functional characterization of a human liver Na+/bile acid cotransporter J Clin Invest 93 1994 1326 1331
58. T. Gerloff, B. Stieger, B. Hagenbuch, J. Madon, L. Landmann, J. Roth, and et al. The sister of P-glycoprotein represents the canalicular bile salt export pump of mammalian liver J Biol Chem 273 1998 10046 10050
59. J.J. Smit, A.H. Schinkel, R.P. Oude Elferink, A.K. Groen, E. Wagenaar, L. van Deemter, and et al. Homozygous disruption of the murine mdr2 P-glycoprotein gene leads to a complete absence of phospholipid from bile and to liver disease Cell 75 1993 451 462
60. F. Iannelli, A. Collino, S. Sinha, E. Radaelli, P. Nicoli, L. D'Antiga, and et al. Massive gene amplification drives paediatric hepatocellular carcinoma caused by bile salt export pump deficiency Nat Commun 5 2014 3850
61. E. Jacquemin, J.M. De Vree, D. Cresteil, E.M. Sokal, E. Sturm, M. Dumont, and et al. The wide spectrum of multidrug resistance 3 deficiency: from neonatal cholestasis to cirrhosis of adulthood Gastroenterology 120 2001 1448 1458
62. E. Jacquemin, D. Cresteil, S. Manouvrier, O. Boute, and M. Hadchouel Heterozygous non-sense mutation of the MDR3 gene in familial intrahepatic cholestasis of pregnancy Lancet 353 1999 210 211
63. O. Rosmorduc, B. Hermelin, and R. Poupon MDR3 gene defect in adults with symptomatic intrahepatic and gallbladder cholesterol cholelithiasis Gastroenterology 120 2001 1459 1467
64. R. Poupon, O. Rosmorduc, P.Y. Boelle, Y. Chretien, C. Corpechot, O. Chazouilleres, and et al. Genotype-phenotype relationships in the low-phospholipid-associated cholelithiasis syndrome: a study of 156 consecutive patients Hepatology 58 2013 1105 1110
65. S.S. Strautnieks, J.A. Byrne, L. Pawlikowska, D. Cebecauerova, A. Rayner, L. Dutton, and et al. Severe bile salt export pump deficiency: 82 different ABCB11 mutations in 109 families Gastroenterology 134 2008 1203 1214
66. L.W. Klomp, J.C. Vargas, S.W. van Mil, L. Pawlikowska, S.S. Strautnieks, M.J. van Eijk, and et al. Characterization of mutations in ATP8B1 associated with hereditary cholestasis Hepatology 40 2004 27 38
67. A. Groen, M.R. Romero, C. Kunne, S.J. Hoosdally, P.H. Dixon, C. Wooding, and et al. Complementary functions of the flippase ATP8B1 and the floppase ABCB4 in maintaining canalicular membrane integrity Gastroenterology 141 2011 e1921 e1924
68. L. Pawlikowska, S. Strautnieks, I. Jankowska, P. Czubkowski, K. Emerick, A. Antoniou, and et al. Differences in presentation and progression between severe FIC1 and BSEP deficiencies J Hepatol 53 2010 170 178
69. A. Davit-Spraul, M. Fabre, S. Branchereau, C. Baussan, E. Gonzales, B. Stieger, and et al. ATP8B1 and ABCB11 analysis in 62 children with normal gamma-glutamyl transferase progressive familial intrahepatic cholestasis (PFIC): phenotypic differences between PFIC1 and PFIC2 and natural history Hepatology 51 2010 1645 1655
70. A.S. Knisely, S.S. Strautnieks, Y. Meier, B. Stieger, J.A. Byrne, B.C. Portmann, and et al. Hepatocellular carcinoma in ten children under five years of age with bile salt export pump deficiency Hepatology 44 2006 478 486
71. S.W. Van Mil, W.L. van der Woerd, G. van der Brugge, E. Sturm, P.L. Jansen, L.N. Bull, and et al. Benign recurrent intrahepatic cholestasis type 2 is caused by mutations in ABCB11 Gastroenterology 127 2004 379 384
72. V.E. Carlton, B.Z. Harris, E.G. Puffenberger, A.K. Batta, A.S. Knisely, D.L. Robinson, and et al. Complex inheritance of familial hypercholanemia with associated mutations in TJP2 and BAAT Nat Genet 34 2003 91 96
73. J.M. Stapelbroek, K.J. van Erpecum, L.W. Klomp, and R.H. Houwen Liver disease associated with canalicular transport defects: current and future therapies J Hepatol 52 2010 258 271
74. H.E. Wasmuth, H. Keppeler, U. Herrmann, R. Schirin-Sokhan, M. Barker, and F. Lammert Coinheritance of Gilbert syndrome-associated UGT1A1 mutation increases gallstone risk in cystic fibrosis Hepatology 43 2006 738 741
75. S. Buch, C. Schafmayer, H. Völzke, M. Seeger, J.F. Miquel, S.C. Sookoian, and et al. Loci from a genome-wide analysis of bilirubin levels are associated with gallstone risk and composition Gastroenterology 139 2010 e1942
76. T. Oda, A.G. Elkahloun, B.L. Pike, K. Okajima, I.D. Krantz, A. Genin, and et al. Mutations in the human Jagged1 gene are responsible for Alagille syndrome Nat Genet 16 1997 235 242
77. L. Li, I.D. Krantz, Y. Deng, A. Genin, A.B. Banta, C.C. Collins, and et al. Alagille syndrome is caused by mutations in human Jagged1, which encodes a ligand for Notch1 Nat Genet 16 1997 243 251
78. K.M. Loomes, E. Tsai, L.A. Underkoffler, C. Grochowski, A.M. Falsey, B.M. Kamath, and et al. A genome-wide association study identifies THBS2 as a candidate modifier of liver disease severity in Alagille syndrome Hepatology 60 2014 252A
79. V. Nobili, G. Svegliati-Baroni, A. Alisi, L. Miele, L. Valenti, and P. Vajro A 360-degree overview of paediatric NAFLD: recent insights J Hepatol 58 2013 1218 1229
80. F. Stickel, S. Buch, K. Lau, H. Meyer zu Schwabedissen, T. Berg, M. Ridinger, and et al. Genetic variation in the PNPLA3 gene is associated with alcoholic liver injury in caucasians Hepatology 53 2011 86 95
81. Krawczyk M, Stokes CS, Romeo S, Lammert F. HCC and liver disease risks in homozygous PNPLA3 p. I148M carriers approach monogenic inheritance. J Hepatol 2015;62:980-981.
82. Y.L. Liu, H.L. Reeves, A.D. Burt, D. Tiniakos, S. McPherson, J.B. Leathart, and et al. TM6SF2 rs58542926 influences hepatic fibrosis progression in patients with non-alcoholic fatty liver disease Nat Commun 5 2014 4309
83. M. Krawczyk, P. Portincasa, and F. Lammert PNPLA3-associated steatohepatitis: toward a gene-based classification of fatty liver disease Semin Liver Dis 33 2013 369 379
84. K. Sevastianova, A. Kotronen, A. Gastaldelli, J. Perttilä, A. Hakkarainen, J. Lundbom, and et al. Genetic variation in PNPLA3 (adiponutrin) confers sensitivity to weight loss-induced decrease in liver fat in humans Am J Clin Nutr 94 2011 104 111
85. J. Shen, G.L. Wong, H.L. Chan, R.S. Chan, H.Y. Chan, W.C. Chu, and et al. PNPLA3 gene polymorphism and response to lifestyle modification in patients with nonalcoholic fatty liver disease J Gastroenterol Hepatol 30 2015 139 146
86. R. Medzhitov, D.S. Schneider, and M.P. Soares Disease tolerance as a defense strategy Science 335 2012 936 941
87. G. Schett, D. Elewaut, I.B. McInnes, J.M. Dayer, and M.F. Neurath How cytokine networks fuel inflammation: toward a cytokine-based disease taxonomy Nat Med 19 2013 822 824
88. T.E. Adolph, M.F. Tomczak, L. Niederreiter, H.J. Ko, J. Bock, E. Martinez-Naves, and et al. Paneth cells as a site of origin for intestinal inflammation Nature 503 2013 272 276
89. O.J. Hamming, E. Terczynska-Dyla, G. Vieyres, R. Dijkman, S.E. Jorgensen, H. Akhtar, and et al. Interferon lambda 4 signals via the IFNlambda receptor to regulate antiviral activity against HCV and coronaviruses EMBO J 32 2013 3055 3065
90. L. Prokunina-Olsson, B. Muchmore, W. Tang, R.M. Pfeiffer, H. Park, H. Dickensheets, and et al. A variant upstream of IFNL3 (IL28B) creating a new interferon gene IFNL4 is associated with impaired clearance of hepatitis C virus Nat Genet 45 2013 164 171
91. S. Bibert, T. Roger, T. Calandra, M. Bochud, A. Cerny, N. Semmo, and et al. IL28B expression depends on a novel TT/-G polymorphism which improves HCV clearance prediction J Exp Med 210 2013 1109 1116
92. P.V. Aka, M.H. Kuniholm, R.M. Pfeiffer, A.S. Wang, W. Tang, S. Chen, and et al. Association of the IFNL4-DeltaG allele with impaired spontaneous clearance of hepatitis C virus J Infect Dis 209 2014 350 354
93. S.J. Griffiths, M. Koegl, C. Boutell, H.L. Zenner, C.M. Crump, F. Pica, and et al. A systematic analysis of host factors reveals a Med23-interferon-lambda regulatory axis against herpes simplex virus type 1 replication PLoS Pathog 9 2013 e1003514
94. E. Estrabaud, M. Vidaud, P. Marcellin, and T. Asselah Genomics and HCV infection: progression of fibrosis and treatment response J Hepatol 57 2012 1110 1125
95. H. Abe, H. Ochi, T. Maekawa, C.N. Hayes, M. Tsuge, D. Miki, and et al. Common variation of IL28 affects gamma-GTP levels and inflammation of the liver in chronically infected hepatitis C virus patients J Hepatol 53 2010 439 443
96. M. Krawczyk, R. Müllenbach, S.N. Weber, V. Zimmer, and F. Lammert Genome-wide association studies and genetic risk assessment of liver diseases Nat Rev Gastroenterol Hepatol 7 2010 669 681
97. O.L. Holmen, H. Zhang, Y. Fan, D.H. Hovelson, E.M. Schmidt, W. Zhou, and et al. Systematic evaluation of coding variation identifies a candidate causal variant in TM6SF2 influencing total cholesterol and myocardial infarction risk Nat Genet 46 2014 345 351
98. Kahali B, Liu YL, Daly AK, Day CP, Anstee QM, Speliotes EK. TM6SF2: catch-22 in the fight against nonalcoholic fatty liver disease and cardiovascular disease? Gastroenterology 2015 [epub].
99. H.J. Zimmerman Hepatotoxicity: the adverse effects of drugs and other chemicals on the liver 1999 Lippincott Williams & Wilkins 789
100. N.P. Chalasani, P.H. Hayashi, H.L. Bonkovsky, V.J. Navarro, W.M. Lee, and R.J. Fontana ACG Clinical Guideline: the diagnosis and management of idiosyncratic drug-induced liver injury Am J Gastroenterol 109 2014 950 966 quiz 967
101. C. Weiler-Normann, and C. Schramm Drug induced liver injury and its relationship to autoimmune hepatitis J Hepatol 55 2011 747 749
102. T.J. Urban, A.K. Daly, and G.P. Aithal Genetic basis of drug-induced liver injury: present and future Semin Liver Dis 34 2014 123 133
103. T.J. Urban, Y. Shen, A. Stolz, N. Chalasani, R.J. Fontana, J. Rochon, and et al. Limited contribution of common genetic variants to risk for liver injury due to a variety of drugs Pharmacogenet Genomics 22 2012 784 795
104. G.R. Cutting Cystic fibrosis genetics: from molecular understanding to clinical application Nat Rev Genet 16 2015 45 56
105. D.G. Clayton Prediction and interaction in complex disease genetics: experience in type 1 diabetes PLoS Genet 5 2009 e1000540
106. T.H. Karlsen, E. Melum, and A. Franke The utility of genome-wide association studies in hepatology Hepatology 51 2010 1833 1842
107. A.M. Meynert, M. Ansari, D.R. FitzPatrick, and M.S. Taylor Variant detection sensitivity and biases in whole genome and exome sequencing BMC Bioinformatics 15 2014 247
108. C. Gilissen, J.Y. Hehir-Kwa, D.T. Thung, M. van de Vorst, B.W. van Bon, M.H. Willemsen, and et al. Genome sequencing identifies major causes of severe intellectual disability Nature 511 2014 344 347
109. G.F. Mells, A. Kaser, and T.H. Karlsen Novel insights into autoimmune liver diseases provided by genome-wide association studies J Autoimmun 46 2013 41 54